Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure
Clinical trial NCT02599480 · COMPLETED
Trial details
- NCT number
- NCT02599480
- Sponsor
- Jean-Luc Balligand
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-12
- Primary completion
- 2021-02-26
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.